Mortality due to blaKPC Klebsiella pneumoniae bacteraemia

被引:59
作者
Fraenkel-Wandel, Yedidah [1 ,2 ,3 ]
Raveh-Brawer, David [2 ,3 ]
Wiener-Well, Yonit [2 ,3 ]
Yinnon, Amos M. [1 ,2 ,3 ]
Assous, Marc V. [2 ,4 ]
机构
[1] Shaare Zedek Med Ctr, Div Internal Med, POB 3235, IL-91031 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
[3] Shaare Zedek Med Ctr, Infect Dis Unit, IL-91031 Jerusalem, Israel
[4] Shaare Zedek Med Ctr, Microbiol Lab, IL-91031 Jerusalem, Israel
关键词
RISK-FACTORS; CARBAPENEM; INFECTION; RESISTANCE; OUTCOMES; IMPACT;
D O I
10.1093/jac/dkv414
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To determine the mortality rate secondary to bla(KPC) Klebsiella pneumoniae (KPC/Kp) bacteraemia, compared with that from ESBL-producing K. pneumoniae (ESBL/Kp) bacteraemia, and to determine associated risk factors. This was a retrospective case-control study of all 68 KPC/Kp bacteraemia patients diagnosed since 2006, matched by year of isolation, gender and age, at a ratio of 1:2, to 136 ESBL/Kp bacteraemia patients. There were no demographic differences between the two groups, but there were minor clinical differences. Fewer KPC/Kp study patients than ESBL/Kp control patients had a systolic blood pressure < 90 mmHg (32/68, 47% versus 86/136, 63%, respectively, P=0.02) or urinary catheterization (32/68, 47% versus 90/136, 66%, respectively, P=0.005), while the KPC/Kp bacteraemia group had a greater incidence of acute renal failure (45/68, 66% versus 67/136, 49%, respectively, P=0.02). There was no difference between the two groups in duration of hospitalization. The mortality rate of the KPC/Kp bacteraemia group was 44/68 (65%) compared with 54/136 (40%) in the ESBL/Kp bacteraemia control group (P=0.008), which in the multivariate analysis remained highly significant (P < 0.001). Only 11/68 (16%) of KPC/Kp patients were functionally independent at discharge compared with 43/136 (32%) ESBL/Kp patients (P=0.012). The selection of an ESBL/Kp control cohort with a ratio of 1:2 (study versus control group) helped resolve an as yet insufficiently settled question: bacteraemia with KPC/Kp is an independent risk factor for death, justifying the strict adherence to cohorting and isolation procedures.
引用
收藏
页码:1083 / 1087
页数:5
相关论文
共 20 条
[1]   Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13 [J].
Adler, Amos ;
Hussein, Omar ;
Ben-David, Debby ;
Masarwa, Samira ;
Navon-Venezia, Shiri ;
Schwaber, Mitchell J. ;
Carmeli, Yehuda .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (01) :89-92
[2]   Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections [J].
Ben-David, D. ;
Kordevani, R. ;
Keller, N. ;
Tal, I. ;
Marzel, A. ;
Gal-Mor, O. ;
Maor, Y. ;
Rahav, G. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (01) :54-60
[3]   Potential Role of Active Surveillance in the Control of a Hospital-Wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae Infection [J].
Ben-David, Debby ;
Maor, Yasmin ;
Keller, Nathan ;
Regev-Yochay, Gili ;
Tal, Ilana ;
Shachar, Dalit ;
Zlotkin, Amir ;
Smollan, Gill ;
Rahav, Galia .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (06) :620-626
[4]   Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia [J].
Borer, Abraham ;
Saidel-Odes, Lisa ;
Riesenberg, Klaris ;
Eskira, Seada ;
Peled, Nejama ;
Nativ, Ronit ;
Schlaeffer, Francisc ;
Sherf, Michael .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (10) :972-976
[5]   Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control [J].
Carmeli, Y. ;
Akova, M. ;
Cornaglia, G. ;
Daikos, G. L. ;
Garau, J. ;
Harbarth, S. ;
Rossolini, G. M. ;
Souli, M. ;
Giamarellou, H. .
CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) :102-111
[6]  
Centers for Disease Control and Prevention (CDC), MULT REAL TIM PCR DE
[7]  
Clinical and Laboratory Standards Institut, 2014, M100S24 CLSI S
[8]   Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections [J].
Falagas, Matthew E. ;
Tensarli, Giannoula S. ;
Karageorgopoulos, Drosos E. ;
Vardakas, Konstantinos Z. .
EMERGING INFECTIOUS DISEASES, 2014, 20 (07) :1170-1175
[9]   Assessing contemporary intensive care unit outcome:: An updated Mortality Probability Admission Model (MPM0-III) [J].
Higgins, Thomas L. ;
Teres, Daniel ;
Copes, Wayne S. ;
Nathanson, Brian H. ;
Stark, Maureen ;
Kramer, Andrew A. .
CRITICAL CARE MEDICINE, 2007, 35 (03) :827-835
[10]   Carbapenem Resistance Among Klebsiella pneumoniae Isolates: Risk Factors, Molecular Characteristics, and Susceptibility Patterns [J].
Hussein, Khetam ;
Sprecher, Hanna ;
Mashiach, Tania ;
Oren, Ilana ;
Kassis, Imad ;
Finkelstein, Renato .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (07) :666-671